| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30130e80c686e9ce48cc02466476b1cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8003a5f0532a604f46a342f29fed59d8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-11 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-02 |
| filingDate |
2011-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80aeeb936cead557b4247d3d5482bdd3 |
| publicationDate |
2012-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012016429-A1 |
| titleOfInvention |
Compositions and methods for treating hepatitis virus infection |
| abstract |
The present invention provides uses of compositions comprising a yolk or yolk antibody obtained from an egg of a fowl which has been immunized using Helicobacter pylori as an antigen for the manufacture of medicaments, food additives or health care products for treating hepatitis virus infection. The invention also provides compositions for treating hepatitis virus infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111345473-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110495604-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102670795-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108126151-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102716384-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013177947-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107050352-A |
| priorityDate |
2010-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |